INCIVO® (Telaprevir) Receives European Commission Approval For Twice-Daily Dosing For Treatment Of Genotype-1 Chronic Hepatitis C (HCV)
- EMEA Innovative Medicine
- INCIVO® (telaprevir) Receives European Commission Approval
INCIVO® (telaprevir) Receives European Commission Approval
- X (Twitter)
Copy link